1. Home
  2. MPLT vs NOMD Comparison

MPLT vs NOMD Comparison

Compare MPLT & NOMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

N/A

Current Price

$6.99

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Logo Nomad Foods Limited

NOMD

Nomad Foods Limited

N/A

Current Price

$12.25

Market Cap

1.7B

ML Signal

N/A

Company Overview

Basic Information
Metric
MPLT
NOMD
Founded
2018
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2025
2015

Fundamental Metrics

Financial Performance
Metric
MPLT
NOMD
Price
$6.99
$12.25
Analyst Decision
Strong Buy
Buy
Analyst Count
15
5
Target Price
★ $26.54
$13.77
AVG Volume (30 Days)
341.4K
★ 1.2M
Earning Date
12-03-2026
11-04-2026
Dividend Yield
N/A
★ 5.55%
EPS Growth
★ 82.39
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.31
P/E Ratio
★ N/A
$8.38
Revenue Growth
N/A
N/A
52 Week Low
$6.77
$8.99
52 Week High
$40.43
$13.08

Technical Indicators

Market Signals
Indicator
MPLT
NOMD
Relative Strength Index (RSI) 28.92 61.04
Support Level N/A $9.52
Resistance Level $8.58 $12.18
Average True Range (ATR) 0.54 0.25
MACD 0.06 0.04
Stochastic Oscillator 11.29 75.39

Price Performance

Historical Comparison
MPLT
NOMD

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

About NOMD Nomad Foods Limited

Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distributing branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream, and ready meals like pizza. It sells its products through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom.

Share on Social Networks: